Idiopātiska plaušu fibroze (IPF) – svarīga savlaicīga diagnostika1
![50_Percentage](/lv/zales/ipf-skanas/sites/default/files/2023-03/50_percentage.png)
Vairāk nekā pusei no visiem IPF pacientiem sākotnēji tiek kļūdaini diagnosticēti citi biežāk sastopami elpošanas traucējumi, piemēram, astma, hroniska obstruktīva plaušu slimība (HOPS) vai bronhīts. 2,3
![Place-holder-2](/lv/zales/ipf-skanas/sites/default/files/2023-03/Place-holder-2.png)
IPF ir progresējoša, reti sastopama slimība, kas rada neatgriezenisku rētaudu veidošanos plaušās. Plaušu vitālās kapacitātes samazinājums par 5–10% pusgada laikā ievērojami palielina pacienta nāves risku.2
Idiopātiska plaušu fibroze (IPF) –
svarīga savlaicīga diagnostika1
Atcerieties/aizdomājieties par IPF, ja pacientam ir1,4,5-7:
![Symptoms of IPF_1.png](/lv/zales/ipf-skanas/sites/default/files/2023-03/Symptoms%20of%20IPF_1.png)
Tests “Sadzirdiet IPF!”: 5 jautājumi.
Plaušu skaņu ieraksti: Jūs varat noklausīties IPF, HOPS un veselu plaušu skaņas.
Šaltiniai:
- Molina-Molina M, Aburto M, Acosta O, et al. Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis. Exp Rev Resp Med. 2018;12(7):537–539.
- Cosgrove GP, Bianchi P, Danese S, Lederer DJ. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18(1):9.
- Collard HR, Tino G, Noble PW, et al. Patient experiences with pulmonary fibrosis. Respir Med. 2007;101(6):1350–4.
- Raghu G, Remy-Jardin M, Myers JL, et al; on behalf of American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi:10.1164/rccm.201807-1255ST.
- Oldham JM, Noth I. Idiopathic pulmonary fibrosis: early detection and referral. Respir Med. 2014;108(6):819–29.
- American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646–664.
- Borchers AT, et al. Idiopathic pulmonary fibrosis-an epidemiological and pathological review. Clin Rev Allergy Immunol 2011;40:117–134.